396 related articles for article (PubMed ID: 28477440)
1. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.
; Kempen JH; Altaweel MM; Holbrook JT; Sugar EA; Thorne JE; Jabs DA
JAMA; 2017 May; 317(19):1993-2005. PubMed ID: 28477440
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study.
Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group
Ophthalmology; 2015 Oct; 122(10):1976-86. PubMed ID: 26298718
[TBL] [Abstract][Full Text] [Related]
3. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
; Kempen JH; Altaweel MM; Holbrook JT; Jabs DA; Louis TA; Sugar EA; Thorne JE
Ophthalmology; 2011 Oct; 118(10):1916-26. PubMed ID: 21840602
[TBL] [Abstract][Full Text] [Related]
5. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
Jaffe GJ; Lin P; Keenan RT; Ashton P; Skalak C; Stinnett SS
Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
[TBL] [Abstract][Full Text] [Related]
6. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
Tomkins-Netzer O; Lightman S; Drye L; Kempen J; Holland GN; Rao NA; Stawell RJ; Vitale A; Jabs DA;
Ophthalmology; 2015 Nov; 122(11):2351-9. PubMed ID: 26359188
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy.
Kempen JH; Van Natta ML; Friedman DS; Altaweel MM; Ansari H; Dunn JP; Elner SG; Holbrook JT; Lim LL; Sugar EA; Jabs DA;
Am J Ophthalmol; 2020 Nov; 219():303-316. PubMed ID: 32628922
[TBL] [Abstract][Full Text] [Related]
8. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Arcinue CA; Cerón OM; Foster CS
J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
[TBL] [Abstract][Full Text] [Related]
9. Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
Jaffe GJ; Pavesio CE;
Ophthalmology; 2020 Oct; 127(10):1395-1404. PubMed ID: 32624244
[TBL] [Abstract][Full Text] [Related]
10. Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial.
Sen HN; Abreu FM; Louis TA; Sugar EA; Altaweel MM; Elner SG; Holbrook JT; Jabs DA; Kim RY; Kempen JH;
Ophthalmology; 2016 Jan; 123(1):183-90. PubMed ID: 26499920
[TBL] [Abstract][Full Text] [Related]
11. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
Holbrook JT; Sugar EA; Burke AE; Vitale AT; Thorne JE; Davis JL; Jabs DA;
Am J Ophthalmol; 2016 Apr; 164():29-36. PubMed ID: 26748056
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy.
Sugar EA; Venugopal V; Thorne JE; Frick KD; Holland GN; Wang RC; Almanzor R; Jabs DA; Holbrook JT;
Ophthalmology; 2017 Nov; 124(11):1662-1669. PubMed ID: 28624167
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.
; Sugar EA; Holbrook JT; Kempen JH; Burke AE; Drye LT; Thorne JE; Louis TA; Jabs DA; Altaweel MM; Frick KD
Ophthalmology; 2014 Oct; 121(10):1855-62. PubMed ID: 24908205
[TBL] [Abstract][Full Text] [Related]
14. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.
; Kempen JH; Altaweel MM; Holbrook JT; Jabs DA; Sugar EA
Am J Ophthalmol; 2010 Apr; 149(4):550-561.e10. PubMed ID: 20097325
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
[TBL] [Abstract][Full Text] [Related]
16. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
Jaffe GJ; Ben-Nun J; Guo H; Dunn JP; Ashton P
Ophthalmology; 2000 Nov; 107(11):2024-33. PubMed ID: 11054326
[TBL] [Abstract][Full Text] [Related]
17. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial.
Friedman DS; Holbrook JT; Ansari H; Alexander J; Burke A; Reed SB; Katz J; Thorne JE; Lightman SL; Kempen JH;
Ophthalmology; 2013 Aug; 120(8):1571-9. PubMed ID: 23601801
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid implants for chronic non-infectious uveitis.
Reddy A; Liu SH; Brady CJ; Sieving PC; Palestine AG
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD010469. PubMed ID: 36645716
[TBL] [Abstract][Full Text] [Related]
19. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.
Callanan DG; Jaffe GJ; Martin DF; Pearson PA; Comstock TL
Arch Ophthalmol; 2008 Sep; 126(9):1191-201. PubMed ID: 18779477
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid implants for chronic non-infectious uveitis.
Reddy A; Liu SH; Brady CJ; Sieving PC; Palestine AG
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD010469. PubMed ID: 37642198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
